Ablation Technology Market Forecast 2029: Industry Share, Trends, Business Growth Strategies, and Market Analysis
Market growth can be attributed to factors such as the rising demand for minimally invasive procedures and a growing target patient population coupled with the introduction of emerging ablation technologies.

The global Ablation Technology Market, valued at US$5.58 billion in 2023, is forecasted to grow at a robust CAGR of 9.5%, reaching US$6.11 billion in 2024 and an impressive US$9.62 billion by 2029. The drivers for this market include expanding access to healthcare services, an increasing preference for minimally invasive treatments, and the use of ablation procedures in expanded application fields that fuel the ablation technology market growth. Additionally, factors such as a growing number of public campaigns to increase awareness related to early detection, a rise in global healthcare expenditure, and supportive reimbursement policies further contribute to the growth of the ablation technology market. The ablation technology market has experienced a surge on the global level due to lucrative opportunities offered by emerging countries such as India and China. Furthermore, factors such as the expansion of the private healthcare sector and increasing patient population drive the adoption of ablation solutions in the end user facilities.

Download PDF Brochure

Browse in-depth TOC on "Ablation Technology Market"

226 - Tables
64 - Figures
290 – Pages

Driver: Emerging ablation technologies

Pulse-field ablation (PFA) is a potentially effective technique for treating cardiac diseases. This non-thermal technique offers a tissue selectivity feature and protects neighboring tissues from harm. PFA for arrhythmias has produced encouraging findings in most preclinical and clinical studies. Additionally, growing R&D expenditure, promoting clinical trials, and recently approved products have increased the market need for this technology. In 2024, Bio Sense Webster, a division of Johnson & Johnson (US), announced that VARIPULSE had received European CE approval for using pulsed-field ablation to treat symptomatic drug-refractory recurrent paroxysmal atrial fibrillation.

Restraint: Rigorous regulatory framework

The US FDA classifies some ablation devices in Class III and the majority in Class II. Class II devices are subjected to control requirements, extended regulatory procedures, and general control requirements. Additional testing, evaluation, and labeling specifications are measures considered in the regulatory framework, which ultimately enhances the time and financial requirements for the product creation and marketing. The phases of the regulatory process can take long waiting periods, particularly concerning Class II devices with notable limitations; this may hamper innovation, and patients might not be promptly presented with potentially life-saving advances.

Request Sample Pages

This study involved the extensive use of both primary and secondary sources. The research process involved the study of various factors affecting the industry to identify the segmentation types, industry trends, key players, competitive landscape, fundamental market dynamics, and key player strategies.

Secondary Research

The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B), white papers, annual reports, companies house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the ablation technology market. A database of the key industry leaders was also prepared using secondary research.

Primary Research

Primary research was conducted after acquiring extensive knowledge about the global ablation technology market scenario through secondary research. Primary interviews were conducted with market experts from both the demand-side (such as hospitals, research universities, academic institutions, and government institutions, among others) and supply-side respondents (such as presidents, CEOs, vice presidents, directors, general managers, heads of business units, and senior managers) across five major geographies, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East, and Africa. Approximately 30% of the primary interviews were conducted with stakeholders from the demand side, while those from the supply side accounted for the remaining 70%. Primary data for this report was collected through questionnaires, emails, and telephonic interviews.

Market Estimation Methodology

A detailed market estimation approach was followed to estimate and validate the size of the global ablation technology market and other dependent submarkets.

  • Key players in the global ablation technology market were identified through secondary research, and their global market shares were determined through primary and secondary research.
  • The research methodology included the study of the annual and quarterly financial reports & regulatory filings of major market players as well as interviews with industry experts (such as CEOs, VPs, directors, and marketing executives) for detailed insights (both qualitative and quantitative trends) on the ablation technology market. 
  • All percentage shares, splits, and breakdowns for the global ablation technology market were determined by using secondary sources and verified through primary sources.
  • All the key macro indicators affecting the revenue growth of the market segments and sub-segments have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the validated and verified quantitative & qualitative data.

Data Triangulation:

After arriving at the overall size of the global ablation technology market through the above-mentioned methodology, this market was split into several segments and sub-segments. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and sub-segments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both the demand- and supply-side participants.

Report Objectives:

  • To define, describe, and forecast the ablation technology market based on type, product, application, end user, and region
  • To provide detailed information regarding the major factors influencing the growth of the global ablation technology market (such as drivers, restraints, challenges, opportunities, and regulatory landscape, among others)
  • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the global ablation technology market
  • To analyze the opportunities in the global ablation technology market for stakeholders and provide details of the competitive landscape for market leaders
  • To profile key global players and comprehensively analyze their market shares and core competencies
  • To provide a five-year forecast for various market segments in terms of revenue with respect to five main regions, namely, North America (includes the US and Canada), Europe (includes Germany, the UK, France, Italy, and Spain), Asia Pacific (includes Japan, China, India, Australia, and South Korea), Latin America (includes Brazil and Mexico), and the Middle East & Africa
  • To track and analyze competitive developments such as product launches; expansions, and mergers and acquisitions; and research and development activities in the ablation technology market

Recent Developments of Ablation Technology Market

  • In February 2024, Johnson & Johnson (US) received CE mark approval for the VARIPULSE Pulse Field Ablation Platform that helps visualize real-time and enhances workflow.
  • In December 2023, Medtronic (US) approved a Pulse Select Pulsed Field Ablation System that helps treat persistent and paroxysmal atrial fibrillation.

For more information, inquire now! Inquire Now

Content Source:

https://www.prnewswire.com/news-releases/ablation-technology-market-worth-9-62-billion-by-2029-driven-by-emerging-tech-innovations--marketsandmarkets-302229344.html

https://www.marketsandmarkets.com/Market-Reports/ablation-devices-market-791.html

https://www.marketsandmarkets.com/PressReleases/ablation-technology.asp

Ablation Technology Market Forecast 2029: Industry Share, Trends, Business Growth Strategies, and Market Analysis
disclaimer

What's your reaction?

Comments

https://timessquarereporter.com/public/assets/images/user-avatar-s.jpg

0 comment

Write the first comment for this!

Facebook Conversations